Please ensure Javascript is enabled for purposes of website accessibility

Why Illumina, Inc. Stock Popped 16.1% in July

By Steve Symington - Aug 10, 2018 at 6:45PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The genome-sequencing company beat quarterly expectations and increased its full-year guidance last month. Here's what investors need to know.

What happened

Shares of Illumina Inc. (ILMN 0.39%) climbed 16.1%% in July, according to data from S&P Global Market Intelligence, after the genomic-sequencing company announced strong second-quarter 2018 results. 

Nearly all of Illumina's gains came on the final trading day of last month after the company confirmed that its quarterly revenue had climbed 25% year over year, to $830 million, which translated to 74% growth in adjusted earnings, to $212 million, or $1.43 per share. Both the top and bottom lines easily outpaced expectations for earnings of $1.11 per share on revenue of $787 million.

Stock market chart indicating gains with dark blue background

IMAGE SOURCE: GETTY IMAGES.

So what

Illumina CEO Francis deSouza credited the company's growth to "broad demand across applications, systems and geographies." He added that sequencing and array consumables, as well as lab and other services, each climbed over 30% year over year, "highlighting the growing interest in genomic information and its application to research, clinical and consumer markets."

The company also delivered noteworthy new products including a new S4 200 cycle kit on its NovaSeq platform for single-cell and exome sequencing, as well as the NovaSeq S Prime (SP) flow cell, designed for smaller applications that require lower sequencing output.

Now what

If that wasn't enough, Illumina now expects full-year sales to grow roughly 20% (up from between 15% and 16% previously), which should mean full-year adjusted earnings of between $5.35 and $5.45 (up from between $4.75 and $4.85 before). 

In the end, this beat-and-raise performance gave investors more-than-enough reason to celebrate and drive the stock price to a fresh all-time high. I won't be the least bit surprised if the company's upward momentum continues for the foreseeable future.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Illumina, Inc. Stock Quote
Illumina, Inc.
ILMN
$240.75 (0.39%) $0.94

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
327%
 
S&P 500 Returns
116%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/20/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.